| 摘要 |
Compositions and methods for the prevention and treatment of nephropathy, including hypertensive and diabetic nephropathy, and nephropathy associated with insulin resistance and metabolic syndrome are described. Compositions of the invention include a compound that binds to a receptor for the glucagon like peptide-1, an incretin, a glucagon-like peptide-1 (GLP-1), an exendin, or an analog (including an agonist analog), derivative, or variant of any of them. |
| 申请人 |
AMYLIN PHARMACEUTICALS, INC.;BARON, ALAIN, D.;HATHAWAY, DAVID, R.;MISTRY, MAHESH;ROMAN, RICHARD, J. |
发明人 |
BARON, ALAIN, D.;HATHAWAY, DAVID, R.;MISTRY, MAHESH;ROMAN, RICHARD, J. |
